New quadrivalent meningitis vaccine shows promise in large pediatric trial
NCT ID NCT07135986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 study is testing an investigational meningococcal conjugate vaccine (MenACYW) in over 1,600 healthy children and adolescents aged 2 to 17 in China. The vaccine aims to protect against four types of meningococcal bacteria that can cause serious infections like meningitis. Researchers are comparing the new vaccine's immune response and safety to currently licensed meningococcal vaccines in China.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MenACYW conjugate vaccine (MenQuadfi)
- What this could lead to
- If successful, this vaccine could provide broader protection against four types of meningococcal bacteria with a single shot, potentially simplifying vaccination schedules for children and teens.
- What could go wrong
- This is a Phase 3 trial, but it is still testing the vaccine's immune response and safety. The vaccine may not prove superior to existing vaccines, and rare side effects could emerge in larger populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational Site Number : 1561000
Nanning, Guangxi, 530028, China
-
Investigational Site Number : 1561001
Jingxi, 533899, China
-
Investigational Site Number : 1561002
Tengzhou, 543399, China
-
Investigational Site Number : 1561003
Liuzhou, 545100, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults